family slam health trust after pensioner's 'undignified' death.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention... would identify hospitals that are best positioned to treat strokes and establish protocols for emergency responders handling stroke patients..submit a letter to the editor
.